In the future, with the in-depth research and the conduct of clinical trials, BPC 157 is expected to become a safe and effective therapeutic drug, bringing new hope to human health
In the UK, standard maintenance therapy for pernicious anaemia is typically hydroxocobalamin 1mg by intramuscular injection every three months (or every two months if neurological symptoms are present), as per BNF and NICE guidance
Common additions in a B12 IV drip include: Vitamin C for immune support and antioxidant protection
We receive questions about them daily, so we have put together a blog post with some useful information
GHK-Cu start 1mg 3x weekly potentially advancing to daily 3mg
50 SKU OBL-GHKCU-50 100 SKU OBL-GHKCU-100 GHK-Cu - , , ,